Showing results (521-530 of 688) with videos related to

Sort By:
Pageof 69
Arthritis Research & Therapy|November 2, 2006
Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristicsMarjan M C Steenvoorden, Tanja C A Tolboom, Gabri van der Pluijm, et al.
Scientific Reports|December 9, 2022
Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approachTheodor Rumetshofer, Francesca Inglese, Jeroen de Bresser, et al.
Rheumatology (Oxford, England)|October 17, 2015
Impact of pulmonary fibrosis and elevated pulmonary pressures on right ventricular function in patients with systemic sclerosisKai Hang Yiu, Maarten K Ninaber, Lucia J Kroft, et al.
Neuropsychiatric Disease and Treatment|December 30, 2020
Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic ReviewRory C Monahan, Hannelore J L Beaart, Rolf Fronczek, et al.
Gene Therapy|February 7, 2003
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3W H van der Laan, P H A Quax, C A Seemayer, et al.
The Journal of Infectious Diseases|November 26, 2002
Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosyAdalberto R Santos, Philip N Suffys, Patrícia R Vanderborght, et al.
Arthritis and Rheumatism|December 2, 2011
Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritisP Suwannalai, L A van de Stadt, H Radner, et al.
Arthritis and Rheumatism|September 30, 2008
Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and diseaseAndreea Ioan-Facsinay, Annemiek Willemze, David B Robinson, et al.
Annals of the Rheumatic Diseases|December 1, 2010
A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt studyE van der Kooi, N B Klarenbeek, M Güler-Yüksel, et al.
Clinical Rheumatology|December 11, 2012
Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategyL Dirven, N B Klarenbeek, M van den Broek, et al.
Pageof 69